Tell your Members to vote YES on this week’s final LTA vote!!
Voting could start on the year-end package that includes the Lymphedema Treatment Act as early as tomorrow/Thursday! If you haven’t called your members of Congress yet and urged them to
Voting could start on the year-end package that includes the Lymphedema Treatment Act as early as tomorrow/Thursday! If you haven’t called your members of Congress yet and urged them to
As reported earlier today, the Lymphedema Treatment Act has been included in the year-end legislative package! Both chambers will be voting on this package later this week. PLEASE call your
We did it — the Lymphedema Treatment Act has been included in the year-end legislative package!!!! The contents of the package were finally released overnight and will be voted on
A huge thank-you to everyone who has made their phone calls! If you haven’t yet, it’s not too late. And if you tried but had trouble getting through or couldn’t
I apologize for sending multiple messages today, but with the clock ticking down we thought you would want to know the latest news. We are now hearing that decisions on
Representative Rosa DeLaura is the Chair of the House Appropriations Committee, and as such plays an important role in putting together the year-end omnibus package. If you are a constituent,
We had fantastic in-person meetings in DC this week, and it is now clear that if we are going to get the Lymphedema Treatment Act through the Senate this year
We are continuing to push for the Lymphedema Treatment Act to either be included in the year-end legislative package or receive a Senate vote as a stand-alone bill. This week,
This is an actual response one of our advocates received from her Senate office: “Thank you for your advocacy and dedication to this issue. It is people like you who
Join our email list to learn about
changes to insurance coverage, advocacy actions,
new educational materials and more.
Subscribers receive approximately
one email per week with information
from both of our organizations.

